PROPHYlactic Implantation of BIOlogic Mesh in Peritonitis (PROPHYBIOM) (PROPHYBIOM)

October 25, 2014 updated by: Federico Coccolini, A.O. Ospedale Papa Giovanni XXIII
To evaluate the efficacy of the use of swine dermal collagen prosthesis implanted preperitoneally as a prophylactic procedure against incisional hernia in patients operated in urgency/emergency setting in contaminated/infected fields with peritonitis. The aim of the study is to reduce the incidence of incisional hernia from 50% to 20%.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • • Patients aged > 18 years old

    • Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin (peritoneal reactivity, positive Blumberg sign, fever, free air/fluid in abdominal cavity, leucocytosis, increased CRP (C-reactive protein, lactic dehydrogenase (LDH), tachycardia, tachypnea, clinical or radiological evidence/suspect of bowel ischemia)
    • Eventual strong suspect of possible bacterial translocation (reduction of the natural intestinal barrier against bacterial translocation, i.e. bowel ischemia, bowel overdistension, intestinal occlusion, etc.)
    • Surgical indication for midline laparotomy independently from eventual previous laparotomies
    • Informed consent

Exclusion Criteria:

  • • Patients aged < 18 years old

    • Informed consent refusal
    • No Clinical and/or laboratory and/or radiological evidence/signs of peritonitis of any origin.
    • Surgical indication for laparotomies other than midline one
    • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment arm
Patients randomized to this arm will be operated for the primary disease and at the end of the intervention the laparotomy will be closed reinforcing the suture with a swine dermis biological prosthesis positioned sublay
The mesh placement will be preceded by the plane preparation. The subcutaneous tissue will be dissociated from the anterior rectum-muscles fascia. The retro-muscular rectum muscles plane will be dissected preparing a 5-6 cm pouch necessary to the prosthesis positioning. The mesh will be fixed with at least 8 long-lasting absorbable transfix stitched. The prosthesis will be placed with at least a 5 cm overlap. If the peritoneal plane can be sutured a Jackson-Pratt 10 suction drain will be placed under the prosthesis. A Jackson-Pratt 10 suction drain will always be placed over the prosthesis. Anterior rectum fascia will be closed by emi-continuous monofilament suture with an intermediate-reabsorbable-time suture. Another Jackson-Pratt 10 suction drain will be placed over the anterior fascia if the subcutaneous tissue is thick. No subcutaneous suture will be performed. Skin stapler or interrupted stitches will be used to close the skin plane.
Other Names:
  • Biological swine dermis not-cross-linked prosthesis positioning
Active Comparator: Control arm
Patients randomized to this arm will be operated for the primary disease and at the end of the intervention the laparotomy will be closed by emi-continuous monofilament sutures with an intermediate-reabsorbable-time suture
Anterior rectum fascia will be closed by emi-continuous monofilament suture with an intermediate-reabsorbable-time suture. No subcutaneous suture will be performed. Skin stapler or interrupted stitches will be used to close the skin plane.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Incisional hernia rate
Time Frame: 3 months
3 months
Incisional hernia rate
Time Frame: 6 months
6 months
Incisional hernia rate
Time Frame: 12 months
12 months
Incisional hernia rate
Time Frame: 24 months
24 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Mortality
Time Frame: 12 months
12 months
Mortality
Time Frame: 24 months
24 months
Mortality
Time Frame: 6 months
6 months
Mortality
Time Frame: 3 months
3 months
Morbidity
Time Frame: 0 months
0 months
Morbidity
Time Frame: 3 months
3 months
Morbidity
Time Frame: 6 months
6 months
Morbidity
Time Frame: 12 months
12 months
Morbidity
Time Frame: 24 months
24 months
Length of surgery
Time Frame: Day 0
Day 0
Time to drain removal
Time Frame: participants will be followed for the duration of hospital stay, an expected average of 1-2 weeks
participants will be followed for the duration of hospital stay, an expected average of 1-2 weeks
Length of stay in hospital
Time Frame: At the discharge, an expected average of 1-2 weeks after the intervention
At the discharge, an expected average of 1-2 weeks after the intervention
Mortality
Time Frame: 0 months
0 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2014

Primary Completion (Anticipated)

October 1, 2016

Study Completion (Anticipated)

October 1, 2018

Study Registration Dates

First Submitted

October 14, 2014

First Submitted That Met QC Criteria

October 25, 2014

First Posted (Estimate)

October 28, 2014

Study Record Updates

Last Update Posted (Estimate)

October 28, 2014

Last Update Submitted That Met QC Criteria

October 25, 2014

Last Verified

October 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Incisional Hernia

Subscribe